Exhibit Hall Presentation Theater: BTK Inhibitor Considerations in Chronic Lymphocytic Leukemia and Waldenström Macroglobulinemia Patient Populations
Supported by Pharmacyclics, An Abbvie Company and Johnson & Johnson